IRCT2016090410178N10招募中2 期
Comparative bioequivalence study of two sustained release Triptorelin vials manufactured by Ronak Darou and IPSEN in patients with prostate cancer based on biologic response (serum PSA and Testosterone levels)
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 no limit（—）
- 性别
- Male
入选标准
- •Metastatic prostate cancer
- •Signing written consent form
排除标准
- •Hypothalamic pituitary gonadal axis dysfunction
- •Malignancy other than prostate cancer
- •Treatment with other Gonadotropin Releasing Hormone (GnRH) analogues, hormones, radiotherapy or chemotherapy during recent three months
- •Allergy to GnRH, GnRH analogues or to any component of medications
研究者
相似试验
招募中
不适用
Bioequivalency study of two different Metformin formulationsIRCT20111107008022N7Reihaneh Pharmaceutical Company24
尚未招募
Unknown
Bioequivalence study of two different Ciprofloxacin formulationsIRCT20111107008022N13Zagrous Darou Pharmaceutical Company24
尚未招募
不适用
Bioequivalence study of two different Fenofibrate formulationsIRCT20111107008022N10Aviccena Pharmaceutical Company24
招募中
不适用
Bioequivalency study of two different Pantoprazole formulationsHealth volunteers.IRCT20111107008022N8Exir Pharmaceutical Company24
招募中
不适用
Bioequivalence study of two different Metformin formulationsIRCT20111107008022N9Sobhandarou24